Semaglutide injectables
Formulation (FDF) · injectables · —
Formulation (FDF)Confidentiality：Public
- INN / Generic Name
- Semaglutide injectables
- Dosage Form
- injectables
- Strength
- —
- Therapy Area
- Metabolic & Endocrinology
- Indication
- Diabetes mellitus; Weight decreased
- Current Status
- Official FDF licensing catalog (UB732)
- GMP Certification
- EU - EMA; US - FDA
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- Registered (market rights transferable / DCP·NP per market)
- MOQ
- On request
- Lead Time
- On request
- Price Range
- On request
HS Code
3002.15
Registrable Markets
China
Process / Sequence / Exact Price
- Process Summary
- —
- Exact Price